Page last updated: 2024-08-26

yttrium radioisotopes and Local Neoplasm Recurrence

yttrium radioisotopes has been researched along with Local Neoplasm Recurrence in 63 studies

Research

Studies (63)

TimeframeStudies, this research(%)All Research%
pre-19901 (1.59)18.7374
1990's5 (7.94)18.2507
2000's22 (34.92)29.6817
2010's29 (46.03)24.3611
2020's6 (9.52)2.80

Authors

AuthorsStudies
Adhikarla, V; Bading, J; Cao, T; Chen, R; Colcher, D; Dandapani, S; Forman, SJ; Herrera, AF; Karras, N; McTague, P; Mei, M; Nademanee, A; Palmer, J; Poku, EK; Popplewell, L; Sahebi, F; Shively, JE; Simpson, J; Smith, DL; Smith, E; Song, J; Spielberger, R; Thomas, SH; Tsai, NC; Wong, J; Wu, AM; Yamauchi, D; Yazaki, P1
Akarca, US; Akhan, O; Bilgiç, S; Bozkurt, MF; Çakaloğlu, Y; Cantaşdemir, M; Çapa Kaya, G; Çermik, TF; Er, Ö; Ilgıt, E; Küçük, NÖ; Numan, F; Parıldar, M; Türkmen, C1
Akateh, C; Black, SM; Cloyd, JM; Conteh, L; Elliott, E; Miller, ED; Noonan, A; Pawlik, TM; Tsung, A1
Baltacioglu, F; Calik, A; Cobanoglu, U; Kucukaslan, H; Oguz, S; Ones, T; Topaloglu, S1
Karatoprak, S; Kutlu, R1
Argiriadi, P; Bekki, Y; Facciuto, L; Facciuto, ME; Gunasekaran, G; Kamath, A; Kim, E; Lewis, S; Marti, J; Patel, RS; Schiano, TD; Simpson, W; Toshima, T1
Clerc, D; Demartines, N; Halkic, N; Melloul, E1
Abeccassis, M; Abouchaleh, N; Ali, R; Asadi, AA; Atassi, R; Baker, T; Caicedo, JC; Desai, K; Fryer, J; Gabr, A; Ganger, D; Habib, A; Hickey, R; Hohlastos, E; Kulik, L; Lewandowski, RJ; Memon, K; Riaz, A; Salem, R; Vouche, M1
Bahary, N; Bartlett, DL; Choudry, MHA; Dhir, M; Geller, DA; Hogg, ME; Holtzman, MP; Jones, HL; Pingpank, JF; Tsung, A; Wallis Marsh, J; Zeh, HJ; Zenati, MS; Zureikat, AH1
Dadia, S; Drexler, M; Farkash, U; Frenkel Rutenberg, T; Gortzak, Y; Kollender, Y; Kramer, M; Morag, G; Rath, E; Sternheim, A; Vitenberg, M1
Abecassis, M; Abouchaleh, N; Ali, R; Baker, T; Caicedo, J; Gabr, A; Katariya, N; Lewandowski, RJ; Riaz, A; Salem, R1
Arreaza, JA; Stauffer, JA; Tsamalaidze, L1
Bagni, O; Cianni, R; Di Costanzo, GG; Filippi, L; Pelle, G; Schillaci, O; Tortora, R1
Belli, ML; Cicone, F; Cremonesi, M; Ferrari, ME; Guidi, C; Paganelli, G; Sarnelli, A; Wahl, R1
Kim, HC1
Abayaweera, G; Abou-Taleb, HA; AbouElhassan, KM; AbouTaleb, HA; Adair, LS; Adams, E; Addison, O; Addy, I; Akhtar, N; Alten, B; Anesini, J; Añez, R; Angaridis, PA; Aouba, A; Arakawa, K; Aumeeruddy-Elalfi, Z; Bao, LP; Basu, E; Bayraktar, E; Bekkelund, CS; Bell, J; Beraldo, H; Bermúdez, V; Betenbaugh, MJ; Bhattacharya, R; Bienvenu, B; Bolzoni, M; Bootz, F; Borja, JB; Bove, DG; Bowden, ME; Bradsher, C; Brockstedt, D; Brothers, RM; Buschauer, A; Calandriello, L; Caporossi, A; Carba, DB; Carratalà, J; Castella, B; Caviezel, D; Ceccato, R; Charalambidis, G; Charisiadis, A; Chattopadhyay, P; Chen, Q; Chen, W; Chen, Y; Chen, YT; Chen, ZJ; Chen, ZY; Cheng, MA; Cheng, ZB; Cherevko, S; Cheung, IY; Cheung, NV; Chiappini, A; Chiu, YL; Choi, IG; Chough, S; Chung, CY; Cobb, A; Colotto, A; Continentino, MA; Cook, AJMC; Costa, F; Coutsolelos, AG; Cuperus, N; Curtis, BM; Davenport, AJ; de Boysson, H; Dela, F; Deng, XP; Deshayes, S; Dhara, K; Dietrich, D; Dietrich, J; Dilhari, A; Ding, R; Ding, Y; Dirè, S; Dohlmann, TL; Dotsenko, A; Doubrovina, E; Du, K; Du, ZJ; Duvic, M; Eastman, A; Eliakim-Raz, N; Elz, S; Emile, JF; Emmerling, C; Engelhard, MH; Eriksson, JG; Etzold, BJM; Faini, AC; Falsini, B; Farmer, E; Fei, JJ; Ferreira, IP; Föttinger, K; Franconieri, F; Fryda, NJ; Fuentes, I; Galateau-Sallé, F; Ganguly, M; Gani, BA; Gao, X; Gao, XF; Gao, XJ; García-Mendiola, T; Garg, A; Gascon, J; Gayani, B; Gevensleben, H; Gilbert, M; Giudiceandrea, A; Giuliani, N; Gocmen, AY; Goldman, DA; Goltz, D; Gombert, AK; Gomila, A; Goodwin, P; Górnicki, K; Gostin, PF; Graterol, M; Gremillet, C; Grier, S; Grün, AL; Gusakov, A; Halldórsdóttir, HR; Han, L; Han, Z; Hävecker, M; Helge, JW; Heo, K; Hernández, JD; Hindsø, M; Holmen Olofsson, G; Hong, CE; Hong, J; Horenstein, AL; Hosenally, M; Hruz, P; Hsu, HL; Hsu, KC; Hu, SF; Hu, Y; Huang, K; Huang, S; Huang, WH; Humaira, A; Hung, CF; Hung, WS; Huo, XK; Huvinen, E; Idorn, M; Ignatyev, K; Im, WT; Ismaël, IS; Jakobsson, JG; Janaszek-Mańkowska, M; Jeong, GT; Ji, L; Ji, X; Jiang, Y; Jo, IH; Jo, SH; Johnson, AC; Johnson, LE; Kadirvelu, K; Kahnt, A; Kaleta, A; Kamiya, T; Kang, DH; Kang, XH; Kashiwagi, T; Katayama, E; Kawachi, N; Keller, M; Kellermann, L; Khan, T; Khan, ZA; Kharshoum, RM; Khim, JS; Kikuchi, M; Kim, BS; Kim, DS; Kim, DW; Kim, JH; Kim, JJ; Kim, JU; Kim, SK; Kim, WS; Kimura, J; Kiss, C; Knop-Gericke, A; Kobayashi, S; Koivusalo, SB; Kolar, E; Kottegoda, N; Kramer, K; Kristiansen, G; Kruger, AA; Kumar, S; Kumar, V; Kumarage, S; Kursungoz, C; Kushner, BH; Kuwahara, F; Kuzawa, C; Kwon, BO; Landsberg, J; Larsen, S; Lauer, P; Le Luduec, JB; Lee, DW; Lee, H; Lee, HY; Lee, JW; Lee, MJ; Lee, SW; Lefrançois, P; Leibovici, L; Leong, KK; Leong, M; Li, B; Li, D; Li, G; Li, J; Li, YZ; Liang, JH; Liang, X; Liens, A; Ligorio, G; Lin, JD; Lindholm, MG; Liou, MJ; List-Kratochvil, EJW; Litvinov, IV; Liu, F; Liu, S; Liu, Y; Liu, Z; Lohar, S; Lopes, MTP; Lorenzo, E; Lu, X; Lukashuk, L; Lukens, WL; Luo, HR; Luo, L; Luttik, MAH; Ma, Y; MacGowan, A; Mahomoodally, MF; Maissen, S; Malavasi, F; Malhotra, M; Mallik, S; Manna, D; Mans, R; Marangoni, D; Marimpietri, D; Marques, F; Marques, WL; Marsaa, K; Martin Silva, N; Martinez, A; Martínez, MS; Massaia, M; Mayrhofer, KJJ; McDade, T; McNeel, DG; Met, Ö; Micalizio, GC; Modak, S; Morandi, F; Moreau, L; Morla, S; Morrell, AP; Morris, S; Mubarak, Z; Muchlisin, ZA; Munoz, M; Nagao, Y; Nakama, T; Nakamura, H; Nakano, T; Nardi, MV; Nasirian, A; Nelson, MD; Netchiporouk, E; Ni, X; Niess, JH; Nijenhuis, JM; Nikolaou, V; O'Connor, BJ; O'Reilly, RJ; Odobel, F; Ohata, C; Ohyama, B; Olivar, LC; Ordoñez, MG; Ostrovnaya, I; Palmar, J; Panda, S; Pandiyarajan, S; Park, B; Park, H; Park, JH; Park, S; Pasquali, L; Patik, JC; Pearce, CI; Peele, ME; Peng, S; Perera, IC; Petty, JT; Pidko, EA; Pinheiro, CB; Pistoia, V; Pita, M; Planchat, A; Plass, F; Pockes, S; Pradhan, N; Premasudha, P; Pronk, JT; Provost, N; Pujol, M; Qi, P; Qiu, J; Qiu, Z; Quan, J; Quaranta, A; Ra, CH; Rameshan, R; Ranglack, DH; Rausch-Fan, X; Rieger, E; Rivas, JR; Roberts, SS; Rocha, WR; Rodrigues, GLS; Rojas, J; Roy, P; Rozhkova, A; Rufo, S; Rupprechter, G; Saeui, CT; Saha, A; Sakai, M; Salazar, J; Salem, HF; Salgarello, T; Samarakoon, SR; Sandau, C; Sandbeck, DJS; Santos, AF; Santos, VG; Sara, Y; Saslow, SA; Sasseville, D; Sato, S; Sauer, JD; Schlögl, R; Schweiger, MJ; Shashkov, I; Shaw, E; Shen, WQ; Shim, J; Shu, J; Singh, C; Sinha Babu, SP; Sinitsyn, A; Sinitsyna, O; Skadborg, SK; Song, Q; Song, W; Stach-Lempinen, B; Stoddart, M; Stoica, M; Street, SR; Sukwong, P; Sun, CP; Sun, J; Sunwoo, IY; Suresh, S; Szécsényi, Á; Takahashi, T; Takeda, S; Tang, D; Tas, ST; Tebé, C; Teixeira, LR; Teixidor, F; Terrier, B; Teschner, D; Tetzlaff, MT; Theisen, E; Thor Straten, P; Tiitinen, A; Timpel, M; Toccoli, T; Torikai, K; Torres, W; Toscani, D; Trad, S; Tsai, HJ; Tseng, CP; Tucker, WJ; Um, W; Vallejo-Torres, L; van den Broek, M; Van den Heuvel, L; van der Woude, LN; van Maris, AJA; Van Schepdael, A; Vank, C; Verucchi, R; Vigo, JM; Viñas, C; Vogt, TJ; Vuong, C; Wai, H; Wang, B; Wang, D; Wang, H; Wang, JJ; Wang, K; Wang, L; Wang, Q; Wang, YR; Watanabe, S; Watters, AK; Weerasekera, MM; Wei, L; Wheeler, DA; Wiegand, I; Wifling, D; Wijesinghe, GK; Winiczenko, R; Wolker, T; Wu, J; Wu, TC; Wu, YY; Xie, P; Xie, YP; Xu, A; Xu, E; Xu, L; Xu, Z; Yamaguchi, M; Yang, A; Yang, G; Yang, J; Yang, TM; Yang, W; Yang, Y; Yarema, KJ; Yesiltepe, M; Yi, KJ; Yigit, N; Yim, UH; Yin, B; Yu, S; Zengin, G; Zhang, B; Zhang, C; Zhang, GR; Zhang, H; Zhang, J; Zhang, L; Zhang, TY; Zhang, X; Zhang, Y; Zhang, YX; Zhao, H; Zhao, JC; Zhao, Z; Zheng, R; Zhou, W; Zorn Morales, N1
Baur-Melnyk, A; Birkenmaier, C; Capellen, CF; Dürr, HR; Jansson, V; Klein, A; Tiling, R1
Dlugosz-Danecka, M; Giza, A; Gruszka, AM; Hubalewska-Dydejczyk, A; Jakobczyk, M; Jurczak, W; Kisiel, E; Knopińska-Posłuszny, W; Krawczyk, K; Skotnicki, A; Sowa Staszczak, A; Szostek, M; Szymczyk, M; Wróbel, T; Zimowska-Curylo, D; Zinzani, PL1
Forero-Torres, A; Knox, SJ; LoBuglio, AF; Meredith, RF; Micallef, IN; Shah, JJ; Shen, S; Vaklavas, C1
Brody, LA; Capanu, M; Carrasquillo, JA; Chou, JF; Do, KG; Garcia, AR; Kemeny, NE; Longing, AP; Pandit-Taskar, N; Petre, EN; Sofocleous, CT1
Behnke, M; Bornstein, K; Cotterell, A; Fisher, RA; Fulcher, A; Lee, DD; Posner, MP; Ramanathan, R; Sharma, A; Stravitz, RT; Sydnor, M1
Coveler, A; Harris, WP; Kwan, SW; Monsky, WL; Padia, SA; Roudsari, B1
Goldenberg, DM; Kio, EA; Misleh, JG; Sharkey, RM; Tomblyn, MB; Wegener, WA; Witzig, TE1
Abad, J; Bowser, I; Gulec, S; Henry, LR; Hostetter, RB; Ressler, B; Schwarz, RE; Vaghefi, H; Yan, M1
Banz, Y; Klaeser, B; Koechli, V; Mueller, BU; Pabst, T1
Boucher, E; Boudjema, K; Edeline, J; Garin, E; Levi Sandri, GB; Meunier, B; Rayar, M; Sulpice, L1
Bergmann, L; Dreyling, M; Ferrero, S; Finke, J; Forstpointner, R; Ghione, P; Hiddemann, W; Keller, U; Passera, R; Pastore, A; Pezzutto, A; Scholz, CW; Trümper, L; Unterhalt, M; Weigert, O1
Ascanio, S; Brandi, G; Cappelli, A; Cucchetti, A; Golfieri, R; Gramenzi, A; Monari, F; Mosconi, C; Pettinato, C; Renzulli, M; Trevisani, F1
Bal, CS; Gupta, SK; Malhotra, A; Sharma, A; Singla, S; Snehlata, EY; Thakral, P; Tyagi, JS; Vashist, A; Yadav, MP1
Abuodeh, Y; Ahmed, KA; Anaya, DA; Biebel, B; Choi, J; El-Haddad, G; Frakes, JM; Hoffe, SE; Kim, R; Kim, Y; Kis, B; Malafa, M; Naghavi, AO; Sweeney, J; Venkat, PS1
Dehm, K; Helmberger, TK; Hoffmann, RT; Jakobs, TF; La Fougere, C; Murthy, R; Reiser, MF; Stemmler, HJ; Tatsch, K; Trumm, C1
Amesur, NB; Devera, MB; Fontes, P; Gamblin, TC; Geller, DA; Heckman, JT; Holloway, SE; Marsh, JW; Nalesnik, M; Steel, JL1
Hamm, B; Jahnke, K; Kiewe, P; Korfel, A; Maza, S; Munz, DL; Thiel, E1
Aricò, D; Baio, SM; Bartolomei, M; Bodei, L; Botteri, E; Cremonesi, M; De Cicco, C; Grana, CM; Paganelli, G; Sansovini, M1
Leahy, MF; Turner, JH1
Eidherr, H; Hoffmann, M; Jonak, C; Muellauer, L; Raderer, M; Traub-Weidinger, T; Troch, M1
Assisi, D; D'Andrea, M; Dessanti, L; Maini, CL; Petti, MC; Pisani, F; Sciuto, R1
Anne, PR; Brown, DB; Doyle, LA; Eschelman, DJ; Frangos, A; Gonsalves, CF; McCann, JW; Petroziello, MF; Sato, T1
Gensure, RH; Haffty, BG; Jabbour, SK; Narra, V; Nosher, JL; Patel, B; Schonewolf, CA1
Ansell, SM; Habermann, TM; Ristow, KM; Wiseman, GA; Witzig, TE1
Fink-Bennett, DM; Thomas, K1
Dunn, WL; Leigh, BR; Stabin, MG; White, CA; Wiseman, GA1
Alavi, A; Goldenberg, DM; Hartzell, KB; Klumpp, TR; Luger, SM; Maillard, I; Nasta, SD; Porter, DL; Schuster, SJ; Sharkey, RM; Stadtmauer, EA; Tsai, DE1
Boerman, OC; Buijs, WC; Oyen, WJ; Postema, EJ1
Bartolomei, M; Bodei, L; Boiardi, A; Botturi, A; Broggi, G; Eoli, M; Lamperti, E; Milanesi, I; Paganelli, G; Rocca, P; Salmaggi, A; Silvani, A1
Fisher, J; Giap, H; Hillebrand, DJ; Marsh, C; Miller, W; Rivera, L; Schaffer, RL1
Altavilla, G; Arrigo, C; Baldari, S; Naro, C; Perniciaro, F; Pitini, V1
Darif, M; Emmanouilides, C; Flinn, IW; Gordon, LI; Macklis, R; Molina, A; Schilder, RJ; Vo, K; Wiseman, GA; Witzig, TE1
DeMonaco, NA; Jacobs, SA; Joyce, J; McCarty, KS1
Fontana, X; Italiano, A; Peyrade, F; Peyrottes, I; Thyss, A1
Adamson, PC; Angiolillo, A; Ayello, J; Cairo, MS; Cooney-Qualter, E; Fawwaz, RA; Harrison, L; Kohl, V; Krailo, M; Perkins, SL; vande Ven, C; Wiseman, G1
Falk, P; Forman, SJ; Fung, HC; Krishnan, A; Molina, A; Nademanee, A; Palmer, JM; Raubitschek, AA; Rodriguez, R; Spielberger, RT; Yamauchi, D1
Abdel-Misih, R; Dignazio, M; Garcia, M; Khatri, J; Neff, R; Petrelli, N; Wilson, P1
Lim, LG; Thamboo, TP; Wai, CT; Wang, SC1
Bullimore, J; Chandler, C; Coakham, H; Hopkins, K; Kemshead, JT; Sandeman, D1
Hopkins, K; Kemshead, JT; Papanastassiou, V1
Chan, M; Ho, R; Ho, S; Johnson, PJ; Lau, WY; Leung, TW; Li, AK1
Chandler, C; Eatough, J; Hopkins, K; Kemshead, JT; Moss, T1
Blackburn, TP; Doughty, D; Plowman, PN1
Bartolomei, M; Broggi, G; Caliceti, P; Chinol, M; Cremonesi, M; Ferrari, M; Gatti, M; Grana, C; Maira, G; Paganelli, G; Prisco, G; Sturiale, C1
Bartolomei, M; Caliceti, P; Chinol, M; De Cicco, C; Fiorenza, M; Gatti, M; Grana, C; Mazzetta, C; Paganelli, G; Robertson, C1
Alcindor, T; Witzig, TE1
Arany, I; Hajda, M; Julow, J; Lányi, F; Pásztor, E; Simkovics, M; Tóth, S1

Reviews

6 review(s) available for yttrium radioisotopes and Local Neoplasm Recurrence

ArticleYear
Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma.
    World journal of gastroenterology, 2019, Jul-28, Volume: 25, Issue:28

    Topics: Ablation Techniques; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Hepatectomy; Humans; Liver; Liver Neoplasms; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Radiosurgery; Treatment Outcome; Yttrium Radioisotopes

2019
Radioembolization for Hepatocellular Carcinoma in Downstaging and Bridging for Liver Transplantation.
    Journal of gastrointestinal cancer, 2020, Volume: 51, Issue:4

    Topics: Brachytherapy; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver; Liver Neoplasms; Liver Transplantation; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Yttrium Radioisotopes

2020
Dosimetric Approaches for Radioimmunotherapy of Non-Hodgkin Lymphoma in Myeloablative Setting.
    Seminars in nuclear medicine, 2022, Volume: 52, Issue:2

    Topics: Antigens, CD20; Humans; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Radioimmunotherapy; Tissue Distribution; Yttrium Radioisotopes

2022
Radioembolization for the treatment of hepatocellular carcinoma.
    Clinical and molecular hepatology, 2017, Volume: 23, Issue:2

    Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver; Liver Neoplasms; Mastectomy, Segmental; Neoplasm Recurrence, Local; Radiopharmaceuticals; Yttrium Radioisotopes

2017
90Y-ibritumomab tiuxetan in the treatment of relapsed or refractory B-cell non-Hodgkin's lymphoma.
    Journal of nuclear medicine technology, 2003, Volume: 31, Issue:2

    Topics: Antibodies, Monoclonal; Humans; Lymphoma, B-Cell; Neoplasm Recurrence, Local; Palliative Care; Radiation Protection; Radioimmunotherapy; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Yttrium Radioisotopes

2003
Radioimmunotherapy with yttrium-90 ibritumomab tiuxetan for patients with relapsed CD20+ B-cell non-Hodgkin's lymphoma.
    Current treatment options in oncology, 2002, Volume: 3, Issue:4

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Humans; Lymphoma, B-Cell; Neoplasm Recurrence, Local; Radioimmunotherapy; Randomized Controlled Trials as Topic; Rituximab; Treatment Outcome; Yttrium Radioisotopes

2002

Trials

21 trial(s) available for yttrium radioisotopes and Local Neoplasm Recurrence

ArticleYear
    Neural computing & applications, 2018, Volume: 30, Issue:6

    Topics: Activities of Daily Living; Acute Disease; Adalimumab; Adaptation, Physiological; Adenosine Triphosphate; Adipose Tissue; Administration, Intravaginal; Adolescent; Adsorption; Adult; Adverse Childhood Experiences; Age Distribution; Age Factors; Aged; Aged, 80 and over; Air Pollution, Indoor; Aldehyde Oxidase; Alginates; Alloys; alpha-Globins; Aluminum Hydroxide; Alveolar Bone Loss; Anaerobiosis; Anesthesia, General; Anesthetics; Animals; Anovulation; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Bacillus cereus; Bacterial Typing Techniques; Bacteroidetes; Base Composition; Biocompatible Materials; Biofilms; Biological Availability; Biological Transport; Biosensing Techniques; Bipolar Disorder; Blood Glucose; Body Mass Index; Bone Regeneration; Boranes; Brachial Artery; Butyric Acid; Candida albicans; Carbon; Carcinoembryonic Antigen; Cell Differentiation; Cell Line, Tumor; Cell Respiration; Cell Survival; Cells, Cultured; Cerebrovascular Circulation; Charcoal; Child; Child Health; China; Chloride Channels; Chlorides; CHO Cells; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromium; Chronic Disease; Chronic Periodontitis; Circular Dichroism; Cities; Cohort Studies; Comamonadaceae; Comorbidity; Coronary Artery Disease; Corrosion; Cricetinae; Cricetulus; Cross Infection; Cross-Sectional Studies; Crowding; Culture Media; Cytokines; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetes, Gestational; Diarylheptanoids; Diclofenac; Disability Evaluation; Diterpene Alkaloids; DNA; DNA Mutational Analysis; DNA, Bacterial; Drug Liberation; Drug Resistance, Multiple, Bacterial; Electrochemical Techniques; Electrodes; Electrolytes; Endothelium, Vascular; Enterococcus faecalis; Epithelial Cell Adhesion Molecule; Epithelial Cells; Erbium; Erythropoietin; Ethanol; Ethylenediamines; Fast Foods; Fatty Acids; Female; Fermentation; Ferric Compounds; Fibroblasts; Flavobacteriaceae; Fluorides; Fluorodeoxyglucose F18; Food Microbiology; Formaldehyde; Furaldehyde; Gamma Cameras; Gene Expression; Geologic Sediments; Glucose Tolerance Test; Glycated Hemoglobin; Glycolipids; Glycosylation; Gracilaria; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Guanine; Health Surveys; HeLa Cells; Hemoglobins, Abnormal; Hexosamines; High Fructose Corn Syrup; High-Intensity Interval Training; Hip Fractures; Hippocampus; HLA-B27 Antigen; Hospitalization; Housing; Humans; Hydrogen-Ion Concentration; Hydrolysis; Hydroxides; Hypercapnia; Hypertension; Hypocreales; Hypromellose Derivatives; Image Processing, Computer-Assisted; Incidence; Indole Alkaloids; Indonesia; Inflammation Mediators; Infrared Rays; Insulin Resistance; Intercalating Agents; Ion Transport; Ionophores; Japan; Kinetics; Kluyveromyces; Letrozole; Linear Models; Lipopolysaccharides; Liposomes; Liver; Lung Diseases; Magnesium Hydroxide; Magnetic Resonance Spectroscopy; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Electron, Transmission; Middle Aged; Mitochondria; Mitochondria, Muscle; Molecular Docking Simulation; Molecular Structure; Muscle, Skeletal; Mutant Proteins; Mutation; Mutation, Missense; Nanocomposites; Nanoparticles; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Nucleic Acid Hybridization; Obesity; Occupational Exposure; Oceans and Seas; Odds Ratio; Organometallic Compounds; Osteogenesis; Ovulation Induction; Oxidation-Reduction; Particle Size; Periodontal Ligament; Permeability; Phaseolus; Phenotype; Philippines; Phosphatidylethanolamines; Phospholipids; Photochemical Processes; Phylogeny; Pichia; Pigmentation; Plant Extracts; Polycystic Ovary Syndrome; Polysaccharides; Postprandial Period; Pregnancy; Pregnancy Rate; Prevalence; Product Surveillance, Postmarketing; Progesterone; Progestins; Protein Engineering; Pseudomonas aeruginosa; Psoriasis; Public Facilities; Rats; Rats, Wistar; Receptors, Thyrotropin; Recombinant Proteins; Reproducibility of Results; Republic of Korea; Retrospective Studies; Rhodobacteraceae; Risk; Risk Assessment; Risk Factors; RNA, Ribosomal, 16S; ROC Curve; Saccharomyces cerevisiae; Salinity; Saliva; Seawater; Seaweed; Sensitivity and Specificity; Sequence Analysis, DNA; Sex Factors; Silver Compounds; Smokers; Social Class; Socioeconomic Factors; Soil Microbiology; Solubility; Soy Foods; Spectrometry, Mass, Electrospray Ionization; Spondylitis, Ankylosing; Staphylococcus aureus; Static Electricity; Steroids; Strontium; Sucrose; Surface Properties; Survival Rate; Sweden; Swine; Synapses; Synchrotrons; Tandem Mass Spectrometry; Tannins; Tea; Temperature; Terpenes; Thalidomide; Thermodynamics; Thiadiazoles; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Time Factors; Tissue Distribution; Titanium; Toilet Facilities; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ubiquinone; Urinary Tract Infections; Vaginal Creams, Foams, and Jellies; Venezuela; Vitamin K 2; Waist Circumference; Waste Disposal, Fluid; Wastewater; Water Microbiology; Water Pollutants, Chemical; Whole Body Imaging; X-Ray Diffraction; Young Adult; Ytterbium; Yttrium; Yttrium Radioisotopes; Zinc Compounds

2018
Consolidation with
    Leukemia & lymphoma, 2019, Volume: 60, Issue:11

    Topics: Adult; Aged; Antibodies, Monoclonal; Female; Follow-Up Studies; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Poland; Prognosis; Prospective Studies; Radioimmunotherapy; Survival Rate; Yttrium Radioisotopes

2019
Phase I study of a modified regimen of ⁹⁰Yttrium-ibritumomab tiuxetan for relapsed or refractory follicular or transformed CD20+ non-Hodgkin lymphoma.
    Cancer biotherapy & radiopharmaceuticals, 2013, Volume: 28, Issue:5

    Topics: Adult; Aged; Antibodies, Monoclonal; Antigens, CD20; Drug Resistance, Neoplasm; Female; Humans; Lymphoma, Non-Hodgkin; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radioimmunotherapy; Salvage Therapy; Survival Rate; Tissue Distribution; Yttrium Radioisotopes

2013
Phase I trial of selective internal radiation therapy for chemorefractory colorectal cancer liver metastases progressing after hepatic arterial pump and systemic chemotherapy.
    Clinical colorectal cancer, 2014, Volume: 13, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Brachytherapy; Colorectal Neoplasms; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Yttrium Radioisotopes

2014
Anti-CD22 90Y-epratuzumab tetraxetan combined with anti-CD20 veltuzumab: a phase I study in patients with relapsed/refractory, aggressive non-Hodgkin lymphoma.
    Haematologica, 2014, Volume: 99, Issue:11

    Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bone Marrow; Disease Progression; Female; Humans; Indium Radioisotopes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radioimmunotherapy; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes

2014
Consolidation of first remission using radioimmunotherapy with yttrium-90-ibritumomab-tiuxetan in adult patients with Burkitt lymphoma.
    Leukemia research, 2015, Volume: 39, Issue:3

    Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Burkitt Lymphoma; Case-Control Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radioimmunotherapy; Remission Induction; Retrospective Studies; Survival Rate; Young Adult; Yttrium Radioisotopes

2015
Radioimmunotherapy in relapsed/refractory mantle cell lymphoma patients: final results of a European MCL Network Phase II Trial.
    Leukemia, 2016, Volume: 30, Issue:4

    Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Drug Resistance, Neoplasm; Europe; Female; Follow-Up Studies; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prospective Studies; Radioimmunotherapy; Survival Rate; Yttrium Radioisotopes

2016
Preliminary Experience with Yttrium-90-labelled Rituximab (Chimeric Anti CD-20 Antibody) in Patients with Relapsed and Refractory B Cell Non-Hodgkins Lymphoma.
    Current radiopharmaceuticals, 2016, Volume: 9, Issue:2

    Topics: Adult; Aged; Antigens, CD20; Antineoplastic Agents; Disease-Free Survival; Feasibility Studies; Female; Humans; Kaplan-Meier Estimate; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Radioimmunotherapy; Rituximab; Treatment Outcome; Young Adult; Yttrium Radioisotopes

2016
Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation.
    Annals of surgical oncology, 2008, Volume: 15, Issue:11

    Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Cisplatin; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Retrospective Studies; Survival Rate; Yttrium Radioisotopes

2008
First report on a prospective trial with yttrium-90-labeled ibritumomab tiuxetan (Zevalin) in primary CNS lymphoma.
    Neuro-oncology, 2009, Volume: 11, Issue:4

    Topics: Adult; Aged; Antibodies, Monoclonal; Central Nervous System Neoplasms; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Radioimmunotherapy; Remission Induction; Survival Rate; Tissue Distribution; Yttrium Radioisotopes

2009
Peptide receptor radionuclide therapy with (90)Y-DOTATOC in recurrent meningioma.
    European journal of nuclear medicine and molecular imaging, 2009, Volume: 36, Issue:9

    Topics: Adolescent; Adult; Aged; Child; Female; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neoplasm Recurrence, Local; Octreotide; Radiopharmaceuticals; Receptors, Somatostatin; Young Adult; Yttrium Radioisotopes

2009
Radioimmunotherapy of relapsed indolent non-Hodgkin lymphoma with 131I-rituximab in routine clinical practice: 10-year single-institution experience of 142 consecutive patients.
    Blood, 2011, Jan-06, Volume: 117, Issue:1

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Clinical Trials, Phase II as Topic; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Radioimmunotherapy; Remission Induction; Rituximab; Survival Rate; Treatment Outcome; Yttrium Radioisotopes

2011
Side-branch embolization before 90Y radioembolization: rate of recanalization and new collateral development.
    AJR. American journal of roentgenology, 2011, Volume: 197, Issue:1

    Topics: Adult; Aged; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Radiography; Radiopharmaceuticals; Treatment Outcome; Yttrium Radioisotopes

2011
Additional radiation absorbed dose estimates for Zevalin radioimmunotherapy.
    Cancer biotherapy & radiopharmaceuticals, 2003, Volume: 18, Issue:2

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Combined Modality Therapy; Dose-Response Relationship, Radiation; Drug Resistance, Neoplasm; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Recurrence, Local; Prospective Studies; Radioimmunotherapy; Rituximab; Salvage Therapy; Tissue Distribution; Tomography, Emission-Computed; Treatment Outcome; Yttrium Radioisotopes

2003
Intratumoral delivery of mitoxantrone in association with 90-Y radioimmunotherapy (RIT) in recurrent glioblastoma.
    Journal of neuro-oncology, 2005, Volume: 72, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow Diseases; Brain Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Drug Delivery Systems; Glioblastoma; Humans; Infusions, Intralesional; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Pilot Projects; Radioimmunotherapy; Yttrium Radioisotopes

2005
Long-term responses in patients with recurring or refractory B-cell non-Hodgkin lymphoma treated with yttrium 90 ibritumomab tiuxetan.
    Cancer, 2007, May-01, Volume: 109, Issue:9

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Drug Resistance, Neoplasm; Humans; Immunoconjugates; Lymphoma, B-Cell; Neoplasm Recurrence, Local; Radioimmunotherapy; Rituximab; Yttrium Radioisotopes

2007
A phase I study of 90yttrium-ibritumomab-tiuxetan in children and adolescents with relapsed/refractory CD20-positive non-Hodgkin's lymphoma: a Children's Oncology Group study.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, Sep-15, Volume: 13, Issue:18 Pt 2

    Topics: Adolescent; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Bone Marrow; Child; Child, Preschool; Female; Humans; Immunoconjugates; Indium Radioisotopes; Lymphoma, Non-Hodgkin; Male; Neoplasm Recurrence, Local; Radiation Dosage; Radioimmunotherapy; Radiotherapy Dosage; Rituximab; Tissue Distribution; Yttrium Radioisotopes

2007
Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin's lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Jan-01, Volume: 26, Issue:1

    Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Female; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Radioimmunotherapy; Stem Cell Transplantation; Treatment Outcome; Yttrium Radioisotopes

2008
The treatment of patients with recurrent malignant gliomas with intratumoral radioimmunoconjugates.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1996, Volume: 141

    Topics: Antibodies, Monoclonal; Brain Neoplasms; Dose-Response Relationship, Radiation; Glioma; Humans; Immunoconjugates; Injections, Intralesional; Iodine Radioisotopes; Metabolic Clearance Rate; Neoplasm Recurrence, Local; Radioimmunotherapy; Radiotherapy Dosage; Relative Biological Effectiveness; Survival Rate; Yttrium Radioisotopes

1996
Pre-targeted locoregional radioimmunotherapy with 90Y-biotin in glioma patients: phase I study and preliminary therapeutic results.
    Cancer biotherapy & radiopharmaceuticals, 2001, Volume: 16, Issue:3

    Topics: Adult; Aged; Antibodies, Monoclonal; Avidin; Biotin; Brain Neoplasms; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Radioimmunotherapy; Radiotherapy Dosage; Tenascin; Tissue Distribution; Yttrium Radioisotopes

2001
Pretargeted adjuvant radioimmunotherapy with yttrium-90-biotin in malignant glioma patients: a pilot study.
    British journal of cancer, 2002, Jan-21, Volume: 86, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Avidin; Biotin; Brain Neoplasms; Female; Glioblastoma; Glioma; Humans; Immunoconjugates; Male; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Yttrium Radioisotopes

2002

Other Studies

36 other study(ies) available for yttrium radioisotopes and Local Neoplasm Recurrence

ArticleYear
Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma.
    Blood advances, 2021, 12-14, Volume: 5, Issue:23

    Topics: Antineoplastic Combined Chemotherapy Protocols; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Radioimmunotherapy; Tissue Distribution; Transplantation Conditioning; Tumor Microenvironment; Yttrium Radioisotopes

2021
The position of transarterial chemoembolization with drug-eluting beads and yttrium-90 transarterial radioembolization in patients with hepatocellular carcinoma: Consensus statements from a Delphi-method expert panel in Turkey.
    Diagnostic and interventional radiology (Ankara, Turkey), 2021, Volume: 27, Issue:6

    Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Consensus; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Pharmaceutical Preparations; Quality of Life; Treatment Outcome; Turkey; Yttrium Radioisotopes

2021
Is it Possible to Increase Survival of Patients with Intrahepatic Cholangiocarcinoma? A Case Report.
    Journal of gastrointestinal cancer, 2021, Volume: 52, Issue:1

    Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Chemoradiotherapy, Adjuvant; Cholangiocarcinoma; Cholecystectomy; Fatal Outcome; Fluorouracil; Hepatectomy; Humans; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Reoperation; Time Factors; Yttrium Radioisotopes

2021
A comparative study of portal vein embolization versus radiation lobectomy with Yttrium-90 micropheres in preparation for liver resection for initially unresectable hepatocellular carcinoma.
    Surgery, 2021, Volume: 169, Issue:5

    Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Hepatectomy; Humans; Hypertrophy; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; New York City; Retrospective Studies; Yttrium Radioisotopes

2021
[Current surgical treatment for hepatocellular carcinoma : critical appraisal of current guidelines].
    Revue medicale suisse, 2017, Jun-14, Volume: 13, Issue:567

    Topics: Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Embolization, Therapeutic; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Practice Guidelines as Topic; Treatment Outcome; Yttrium Radioisotopes

2017
Comparative study of post-transplant outcomes in hepatocellular carcinoma patients treated with chemoembolization or radioembolization.
    European journal of radiology, 2017, Volume: 93

    Topics: alpha-Fetoproteins; Brachytherapy; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver Neoplasms; Liver Transplantation; Neoplasm Recurrence, Local; Proportional Hazards Models; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes

2017
Effectiveness of Hepatic Artery Infusion (HAI) Versus Selective Internal Radiation Therapy (Y90) for Pretreated Isolated Unresectable Colorectal Liver Metastases (IU-CRCLM).
    Annals of surgical oncology, 2018, Volume: 25, Issue:2

    Topics: Antimetabolites, Antineoplastic; Brachytherapy; Colorectal Neoplasms; Combined Modality Therapy; Embolization, Therapeutic; Female; Floxuridine; Follow-Up Studies; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Survival Rate; Yttrium Radioisotopes

2018
Inconclusive benefit of adjuvant
    The bone & joint journal, 2018, Volume: 100-B, Issue:7

    Topics: Adult; Durapatite; Female; Follow-Up Studies; Humans; Injections, Intra-Articular; Knee Joint; Male; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Retrospective Studies; Synovectomy; Synovial Membrane; Synovitis, Pigmented Villonodular; Treatment Outcome; Yttrium Radioisotopes

2018
Outcomes of Surgical Resection after Radioembolization for Hepatocellular Carcinoma.
    Journal of vascular and interventional radiology : JVIR, 2018, Volume: 29, Issue:11

    Topics: Adult; Aged; Biopsy; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Hepatectomy; Humans; Liver Neoplasms; Liver Regeneration; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Progression-Free Survival; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Yttrium Radioisotopes

2018
Transarterial Radiation Lobectomy, Portal Vein Embolization, and Staged Hepatectomy for Multiple Bilobar Metachronous Colorectal Liver Metastasis.
    The American surgeon, 2018, Apr-01, Volume: 84, Issue:4

    Topics: Angiography; Colorectal Neoplasms; Embolization, Therapeutic; Hepatectomy; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Portal Vein; Yttrium Radioisotopes

2018
Repeated Treatment with
    Cancer biotherapy & radiopharmaceuticals, 2019, Volume: 34, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Liver; Male; Microspheres; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiotherapy, Adjuvant; Retreatment; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes

2019
The effects of radiosynoviorthesis in pigmented villonodular synovitis of the knee.
    Archives of orthopaedic and trauma surgery, 2019, Volume: 139, Issue:5

    Topics: Adult; Brachytherapy; Female; Humans; Knee Joint; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Synovectomy; Synovitis, Pigmented Villonodular; Yttrium Radioisotopes

2019
Multimodality therapy and liver transplantation for hepatocellular carcinoma: a 14-year prospective analysis of outcomes.
    Transplantation, 2014, Jul-15, Volume: 98, Issue:1

    Topics: Aged; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Hepatectomy; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Niacinamide; Phenylurea Compounds; Prospective Studies; Protein Kinase Inhibitors; Radiopharmaceuticals; Radiotherapy, Adjuvant; Risk Factors; Sorafenib; Time Factors; Treatment Outcome; Yttrium Radioisotopes

2014
Superselective yttrium-90 radioembolization for hepatocellular carcinoma yields high response rates with minimal toxicity.
    Journal of vascular and interventional radiology : JVIR, 2014, Volume: 25, Issue:7

    Topics: Aged; Angiography, Digital Subtraction; Carcinoma, Hepatocellular; Disease Progression; Embolization, Therapeutic; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Yttrium Radioisotopes

2014
Liver resection for metastatic disease after y90 radioembolization: a case series with long-term follow-up.
    Annals of surgical oncology, 2015, Volume: 22, Issue:2

    Topics: Aged; Combined Modality Therapy; Embolization, Therapeutic; Female; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Organ Size; Spleen; Yttrium Radioisotopes

2015
Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment.
    Annals of surgical oncology, 2015, Volume: 22, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Cholangiocarcinoma; Combined Modality Therapy; Embolization, Therapeutic; Female; Follow-Up Studies; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Yttrium Radioisotopes

2015
Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study.
    British journal of cancer, 2016, 07-26, Volume: 115, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Cholangiocarcinoma; Embolization, Therapeutic; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis; Yttrium Radioisotopes

2016
Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization.
    World journal of gastroenterology, 2016, Dec-21, Volume: 22, Issue:47

    Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chi-Square Distribution; Disease Progression; Disease-Free Survival; Embolization, Therapeutic; Female; Florida; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Microspheres; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Yttrium Radioisotopes

2016
Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases.
    Journal of vascular and interventional radiology : JVIR, 2008, Volume: 19, Issue:8

    Topics: Antineoplastic Agents; Brachytherapy; Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Treatment Failure; Treatment Outcome; Yttrium Radioisotopes

2008
90Y-ibritumomab tiuxetan (Zevalin) in heavily pretreated patients with mucosa associated lymphoid tissue lymphoma.
    Leukemia & lymphoma, 2011, Volume: 52, Issue:1

    Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Neoplasm Recurrence, Local; Radioimmunotherapy; Remission Induction; Retrospective Studies; Rituximab; Salvage Therapy; Survival Rate; Treatment Outcome; Young Adult; Yttrium Radioisotopes

2011
FCR (Fludarabine, Cyclophosphamide, Rituximab) regimen followed by 90Yttrium ibritumomab tiuxetan consolidation for the treatment of relapsed grades 1 and 2 follicular lymphoma: a report of 9 cases.
    Journal of experimental & clinical cancer research : CR, 2011, Feb-08, Volume: 30

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Feasibility Studies; Female; Humans; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radioimmunotherapy; Retrospective Studies; Rituximab; Vidarabine; Yttrium Radioisotopes

2011
Patterns of failure in colorectal patients with liver metastases after yttrium-90 radioembolization.
    American journal of clinical oncology, 2014, Volume: 37, Issue:3

    Topics: Adult; Aged; Colorectal Neoplasms; Disease-Free Survival; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Resins, Synthetic; Retrospective Studies; Risk Assessment; Risk Factors; Salvage Therapy; Tomography, X-Ray Computed; Treatment Failure; Yttrium Radioisotopes

2014
Subsequent chemotherapy regimens are well tolerated after radioimmunotherapy with yttrium-90 ibritumomab tiuxetan for non-Hodgkin's lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Sep-15, Volume: 20, Issue:18

    Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Radioimmunotherapy; Retrospective Studies; Salvage Therapy; Treatment Outcome; Yttrium Radioisotopes

2002
Use of ibritumomab tiuxetan anti-CD20 radioimmunotherapy in a non-Hodgkin's lymphoma patient previously treated with a yttrium-90-labeled anti-CD22 monoclonal antibody.
    Clinical lymphoma, 2003, Volume: 4, Issue:1

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD; Antigens, CD20; Antigens, Differentiation, B-Lymphocyte; B-Lymphocytes; Cell Adhesion Molecules; Disease Progression; Humans; Lectins; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Radioimmunotherapy; Radiopharmaceuticals; Sialic Acid Binding Ig-like Lectin 2; Treatment Outcome; Yttrium Radioisotopes

2003
Underestimation of absorbed dose to kidney.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Humans; Kidney; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Recurrence, Local; Radiation Dosage; Radioimmunotherapy; Radiotherapy Dosage; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Yttrium Radioisotopes

2003
Hepatic intra-arterial infusion of yttrium-90 microspheres in the treatment of recurrent hepatocellular carcinoma after liver transplantation: a case report.
    World journal of gastroenterology, 2006, Sep-21, Volume: 12, Issue:35

    Topics: Adult; Carcinoma, Hepatocellular; Hepatitis C; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Liver Transplantation; Male; Microspheres; Neoplasm Recurrence, Local; Neoplasm Staging; Treatment Outcome; Yttrium Radioisotopes

2006
Salvage therapy for primary central nervous system lymphoma with (90)Y-Ibritumomab and Temozolomide.
    Journal of neuro-oncology, 2007, Volume: 83, Issue:3

    Topics: Aged; Antibodies, Monoclonal; Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Female; Humans; Lymphoma; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Radioimmunotherapy; Remission Induction; Salvage Therapy; Survival Rate; Temozolomide; Yttrium Radioisotopes

2007
Focal radiation fibrosis after radioimmunotherapy for follicular non-Hodgkin lymphoma.
    Clinical lymphoma & myeloma, 2007, Volume: 7, Issue:5

    Topics: Aged; Antibodies, Monoclonal; Diagnosis, Differential; Dose-Response Relationship, Radiation; Humans; Laryngeal Neoplasms; Lung Neoplasms; Lymphoma, Follicular; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Pneumonitis; Radioimmunotherapy; Recurrence; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes

2007
Retreatment with 90Y-labelled ibritumomab tiuxetan in a patient with follicular lymphoma who had previously responded to treatment.
    The Lancet. Oncology, 2007, Volume: 8, Issue:9

    Topics: Aged; Antibodies, Monoclonal; Humans; Lymphoma, Follicular; Male; Neoplasm Recurrence, Local; Radioimmunotherapy; Retreatment; Yttrium Radioisotopes

2007
The toxicity of liver directed yttrium-90 microspheres in primary and metastatic liver tumors.
    Cancer investigation, 2008, Volume: 26, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Female; Hepatic Artery; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Pancreatic Neoplasms; Retrospective Studies; Survival Rate; Yttrium Radioisotopes

2008
Late gastric ulceration and cytomegalovirus infection following selective internal radiation therapy (SIRT) of the liver.
    Pathology, 2008, Volume: 40, Issue:3

    Topics: Aged; Ascites; Brachytherapy; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cytomegalovirus Infections; Diabetes Mellitus; Hepatic Artery; Humans; Hypertension; Hypertension, Portal; Infusions, Intra-Arterial; Liver Cirrhosis; Liver Neoplasms; Male; Microspheres; Neoplasm Recurrence, Local; Stomach Ulcer; Yttrium Radioisotopes

2008
A pilot study of the treatment of patients with recurrent malignant gliomas with intratumoral yttrium-90 radioimmunoconjugates.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1995, Volume: 34, Issue:2

    Topics: Adolescent; Adult; Aged; Antigens, Surface; Bone Marrow; Brain Edema; Brain Neoplasms; Cell Adhesion Molecules, Neuronal; Child; Dexamethasone; Feasibility Studies; Female; Glioma; Humans; Immunoconjugates; Injections, Intralesional; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Radioimmunotherapy; Radiotherapy Dosage; Yttrium Radioisotopes

1995
Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres.
    International journal of radiation oncology, biology, physics, 1998, Feb-01, Volume: 40, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cause of Death; Dose Fractionation, Radiation; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Survival Analysis; Yttrium Radioisotopes

1998
Direct injection of 90Y MoAbs into glioma tumor resection cavities leads to limited diffusion of the radioimmunoconjugates into normal brain parenchyma: a model to estimate absorbed radiation dose.
    International journal of radiation oncology, biology, physics, 1998, Mar-01, Volume: 40, Issue:4

    Topics: Antibodies, Monoclonal; Biopsy; Brain; Brain Neoplasms; Combined Modality Therapy; Glioma; Humans; Immunoconjugates; Injections, Intralesional; Models, Biological; Neoplasm Recurrence, Local; Radioimmunotherapy; Yttrium Radioisotopes

1998
Stereotactic intracavitary therapy of recurrent cystic craniopharyngioma by instillation of 90yttrium.
    British journal of neurosurgery, 1999, Volume: 13, Issue:4

    Topics: Adult; Brachytherapy; Child; Craniopharyngioma; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pituitary Neoplasms; Salvage Therapy; Tomography, X-Ray Computed; Treatment Outcome; Vision Disorders; Yttrium Radioisotopes

1999
The radiotherapy of cystic craniopharyngioma with intracystic installation of 90Y silicate colloid.
    Acta neurochirurgica, 1985, Volume: 74, Issue:3-4

    Topics: Adolescent; Adult; Brachytherapy; Child; Combined Modality Therapy; Craniopharyngioma; Cysts; Female; Humans; Male; Neoplasm Recurrence, Local; Pituitary Neoplasms; Silicates; Tomography, X-Ray Computed; Yttrium; Yttrium Radioisotopes

1985